Connection

Robert Harrington to Genetic Therapy

Back to Details
This is a "connection" page, showing publications Robert Harrington has written about Genetic Therapy.
Robert Harrington
Connection Strength
0.055
Genetic Therapy
  1. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005 Nov 16; 294(19):2446-54.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.